Clinical Trials in Tennessee

Showing 7101-7120 of 15,329 trials

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

NCT00763555

This was a multicenter, randomized, vehicle-controlled, double-blind parallel group study to evaluate the efficacy and safety of CD 2027 Oily Spray applied twice daily for 8 weeks in participants with plaque-type psoriasis.

Psoriasis

Galderma R&D88 participantsStarted Sep 2008

Fridley, Minnesota, United States • Nashville, Tennessee, United States • Edmonton, Alberta, Canada +3 more locations

COMPLETED29 miles

3T MRI CIED Post-Approval Study

NCT02969395

The purpose of this study is to evaluate product performance of Magnetic Resonance (MR) Conditional Cardiac Implantable Electronic Devices (CIED) following 3 tesla (3T) MRI exposure. This will be achieved by evaluating the changes in pacing capture threshold (PCT) measurements following 3T MRI scan exposure. This study is required by FDA as a condition of approval of 3T MRI compatible labeling of applicable CIED systems. This study is conducted within Medtronic's post-market surveillance platform, the Product Surveillance Registry (PSR).

Cardiac Rhythm Disorder

Medtronic41 participantsStarted Apr 2016

Birmingham, Alabama, United States • Anchorage, Alaska, United States • Chandler, Arizona, United States +201 more locations

Efficacy and Safety Study of CD 2027 Spray in Subjects With Plaque-type Psoriasis

3T MRI CIED Post-Approval Study

Find Trials by Condition in Tennessee

A Study of Gene Edited Autologous Neoantigen Targeted TCR T Cells With or Without Anti-PD-1 in Patients With Solid Tumors

Phase ll Study of Pirfenidone in Patients With RAILD (TRAIL1)

Study of Cosibelimab in Subjects With Relapsed or Refractory Lymphoma

Sapanisertib or Pazopanib Hydrochloride in Treating Patients With Locally Advanced or Metastatic Sarcoma

Efficacy and Safety of Brolucizumab vs Aflibercept in Patients With Visual Impairment Due to Diabetic Macular Edema

A Study of LY3561774 in Participants With Dyslipidemia

Safety, PD & Efficacy of MT-3724 for the Treatment of Patients With Relapsed or Refractory DLBCL

A Global Study Comparing Risankizumab to Placebo in Adult Participants With Moderate to Severe Hidradenitis Suppurativa

Study of Tisagenlecleucel in Combination With Pembrolizumab in r/r Diffuse Large B-cell Lymphoma Patients

Evaluation of the Safety and Efficacy Study of RGN-137 Topical Gel for Junctional and Dystrophic Epidermolysis Bullosa

Genomic Translation for Amyotrophic Lateral Sclerosis Care

Trial to Evaluate Efficacy and Safety of Lenabasum in Dermatomyositis

Rare Genetic Disorders of the Breathing Airways

REFINE Study: A Study In a Novel Interspinous Fusion Device In Subjects With Low Back Pain

A Study of Obinutuzumab (RO5072759) Plus Chemotherapy in Comparison With Rituximab Plus Chemotherapy Followed by Obinutuzumab or Rituximab Maintenance in Patients With Untreated Advanced Indolent Non-Hodgkin's Lymphoma (GALLIUM)

Pazopanib Hydrochloride in Treating Patients With Advanced Angiosarcoma

DOACs for Stroke Prevention Post Ventricular Tachycardia Ablation

Safety, Tolerability and Efficacy of Nidufexor in Patients With Diabetic Nephropathy